J 2022

Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations

ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, Patrik ČECH, Petra ŠMUHAŘOVÁ et. al.

Basic information

Original name

Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations

Authors

ONDROUŠKOVÁ, Eva (203 Czech Republic, belonging to the institution), Michaela BOHÚNOVÁ (703 Slovakia, belonging to the institution), Kristýna ZÁVACKÁ (203 Czech Republic, belonging to the institution), Patrik ČECH (203 Czech Republic, belonging to the institution), Petra ŠMUHAŘOVÁ (203 Czech Republic, belonging to the institution), Miroslav BOUDNÝ (203 Czech Republic, belonging to the institution), Martina ORŠULOVÁ (703 Slovakia, belonging to the institution), Anna PANOVSKÁ (203 Czech Republic, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution) and Marie JAROŠOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2022, 2234-943X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.700

RIV identification code

RIV/00216224:14110/22:00126419

Organization unit

Faculty of Medicine

UT WoS

000821921200001

Keywords in English

chronic lymphocytic leukemia; MYC; complex karyotype; 8q24 gain; prognosis

Tags

International impact, Reviewed
Změněno: 11/8/2022 13:02, Mgr. Tereza Miškechová

Abstract

V originále

Chronic lymphocytic leukemia (CLL) with cytogenetics findings, such as complex karyotype and deletions of TP53 or ATM, is associated with adverse clinical outcomes. Additional chromosomal abnormalities further stratify patients into groups with diverse prognoses. Gain of 8q24 is one of the abnormalities considered as prognostically unfavorable. In our study, we performed a FISH analysis in an initial cohort of 303 consecutive CLL patients and determined the frequency of +8q to be 6.3 %. Our analysis confirmed the association with TP53/ATM aberrations and CK, as the frequency of +8q reached 26.7 % in an extended delTP53/ATM+CK cohort. M-FISH analysis enabled the identification of partner chromosomes where the segment of the duplicated 8q arm was localized. More detailed mapping of the gained 8q region using the M-BAND method determined the smallest amplified region 8q23-8qter. We observed significantly shorter overall survival (OS; 9.0 years in +8q-positive vs. 10.6 years in +8q-negative; p=0.02) and detected slightly higher MYC mRNA/protein levels in +8q-positive vs. +8q-negative patients.

Links

MUNI/A/1330/2021, interní kód MU
Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX (Acronym: VýDiTeHeMa IX)
Investor: Masaryk University
NU21-08-00237, research and development project
Name: Pokročilé sekvenační metody pro analýzu strukturních přestaveb nádorového genomu
Investor: Ministry of Health of the CR, Advanced sequencing methods for deciphering structural variants in cancer genome, Subprogram 1 - standard